Less common but clinically significant adverse effects include hypoglycaemia (particularly when used alongside insulin or sulphonylureas), acute pancreatitis, gallbladder disorders, and hypersensitivity reactions
Diabetes Obes Metab 26(8):31283136
Patient Education Education is at the heart of what we do
[3] [4] PCOS, GLP-1 Treatment and Menstrual Changes Polycystic ovary syndrome (PCOS) affects approximately 10% of women of reproductive age in the UK and is characterised by irregular periods, elevated androgens, and often insulin resistance
For a non-injectable product this result is noteworthy and positions a carefully designed oral supplement program among the most promising natural alternatives to GLP1
This comprehensive assessment forms the foundation for developing an individualized treatment plan that may include behavioral interventions, nutritional counseling, exercise prescription, psychological support, and increasingly, pharmacologic therapy